Cyclophosphamide
Brand name: Procytox
Cyclophosphamide comes in 14 pill versions in our database, in 2 strengths, from 7 manufacturers. Check the imprint to tell them apart.
Cyclophosphamide pill images
25 mg 7 pills
- 54 639 Cyclophosphamide 25 mg Blue, round, 9 mm Used for multiple sclerosis and myasthenia gravis
- 54 006 Cyclophosphamide 25 mg Blue, capsule, 8 mm Used for multiple sclerosis and myasthenia gravis
- A 346 Cyclophosphamide 25 mg Blue, capsule, 16 mm Used for multiple sclerosis and myasthenia gravis
- Cipla 51625MG Cyclophosphamide 25 mg White, capsule, 16 mm Used for multiple sclerosis and myasthenia gravis
- BXT 25 Cyclophosphamide 25 mg White, round, 9 mm Used for multiple sclerosis and myasthenia gravis
- NSP25 Cyclophosphamide 25 mg Blue, capsule, 16 mm Used for multiple sclerosis and myasthenia gravis
- No picture yet DIN 02241795 Cyclophosphamide 25 mg Procytox, Tablet, sold in Canada Used for multiple sclerosis and myasthenia gravis
50 mg 7 pills
- 54 980 Cyclophosphamide 50 mg Blue, round, 11 mm Used for multiple sclerosis and myasthenia gravis
- 54 881 Cyclophosphamide 50 mg Blue, capsule, 10 mm Used for multiple sclerosis and myasthenia gravis
- A 347 Cyclophosphamide 50 mg Blue, capsule, 19 mm Used for multiple sclerosis and myasthenia gravis
- Cipla 51750MG Cyclophosphamide 50 mg White, capsule, 19 mm Used for multiple sclerosis and myasthenia gravis
- BXT 50 Cyclophosphamide 50 mg White, round, 11 mm Used for multiple sclerosis and myasthenia gravis
- NSP50 Cyclophosphamide 50 mg Blue, capsule, 19 mm Used for multiple sclerosis and myasthenia gravis
- No picture yet DIN 02241796 Cyclophosphamide 50 mg Procytox, Tablet, sold in Canada Used for multiple sclerosis and myasthenia gravis
What is Cyclophosphamide used for?
Cyclophosphamide is used for multiple sclerosis, myasthenia gravis, breast cancer and multiple myeloma.
- Medicine type
- Cancer or immune medicine
Official uses from the US prescribing label
Malignant Diseases
Cyclophosphamide capsules are indicated for the treatment of: • malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin’s disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt’s lymphoma • multiple myeloma • leukemias: chronic lymphocytic leukemia, chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis), acute myelogenous and monocytic leukemia, acute lymphoblastic (stem-cell) leukemia (cyclophosphamide given during remission is effective in prolonging its duration) • mycosis fungoides (advanced disease) • neuroblastoma (disseminated disease) • adenocarcinoma of the ovary • retinoblastoma • carcinoma of the breast
Cyclophosphamide capsules, although effective alone in susceptible malignancies, is more frequently used concurrently or sequentially with other antineoplastic drugs.
Minimal Change Nephrotic Syndrome in Pediatric Patients
Cyclophosphamide capsules are indicated for the treatment of biopsy proven minimal change nephrotic syndrome in pediatric patients who failed to adequately respond to or are unable to tolerate adrenocorticosteroid therapy.
Limitations of Use:
The safety and effectiveness of cyclophosphamide capsules for the treatment of nephrotic syndrome in adults or other renal disease has not been established.
From the FDA-approved label on DailyMed (published Sep 29, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.